(InSilico Medicine, Inc.) Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence, announces the presentation of Matt Kaeberlein, Ph.D., Department of Pathology, University of Washington, at 6th Aging Research, Drug Discovery, and AI Forum during the Basel Life Congress, Sept, 10-12, 2019, Basel, Switzerland.

Original source: https://www.eurekalert.org/pub_releases/2019-03/imi-dmk031119.php